Numerai’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45,257
Closed -$508K 761
2025
Q4
$508K Sell
45,257
-73,628
-62% -$842K 0.06% 398
2025
Q3
$1.37M Buy
+118,885
New +$1.39M 0.19% 158
2024
Q3
Sell
-65,249
Closed -$1.3M 355
2024
Q2
$1.3M Sell
65,249
-56,509
-46% -$1.1M 0.47% 62
2024
Q1
$2.42M Buy
+121,758
New +$2.35M 1.05% 20

Other funds holding AVNS

Numerai's AVNS Position: Q1 2026 in Review

Numerai sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 45,257 shares — an estimated $508K sold.

Numerai first reported a position in AVNS in Q1 2024 and held it in 4 quarters. The position peaked at $2.42M in Q1 2024. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Numerai reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Numerai sold 45,257 Avanos Medical shares in Q1 2026, an estimated $508K.
  • Numerai first reported a position in Avanos Medical in Q1 2024 and held it in 4 quarters.
  • Numerai's Avanos Medical position peaked at $2.42M in Q1 2024.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Numerai's 13F filing for Q1 2026, filed 15 May 2026.